Coronavirus

Top news of the week from Pharmacy Times®.

Pharmacy Times® interviewed Nancy Lyons, BSPharm, MBA, CDE, of Health Mart and Pete Slone of McKesson on why provider status for pharmacists is important to consider during the COVID-19 pandemic.

A trial will enroll up to 60,000 participants to assess the safety and efficacy of a COVID-19 vaccine candidate that only requires a single dose.

A recent study found that patients on immunosuppressive therapy for common skin and rheumatic diseases, such as psoriasis and rheumatoid arthritis, are not at an increased risk for contracting COVID-19.

In a recent Pharmacy Times® webcast, several experts discussed how pharmacists’ roles are changing and some of the new precautions implemented at pharmacies.

Pharmacy Times® interviewed Ramzi Yacoub, chief pharmacy officer at SingleCare, on how data from SingleCare has shown an intense surge in demand for the flu vaccine this year.

Recent studies have analyzed how individuals with autoimmune conditions prescribed specialty medications may be affected by the COVID-19 pandemic.

Pharmacy Times® interviewed Keri Donaldson, medical director and CEO of Prescient Medicine, about the effects of the COVID-19 pandemic on the opioid epidemic in the United States.

News consumption was found to be an especially strong predicative factor for acute stress and depression during the COVID-19 pandemic.

Policy makers and public health officials should not discount the importance of relationships in vaccination game plans.

The new study suggests that COVID-19 will follow the track of other respiratory viruses and become seasonal in countries with temperate climates, but only when herd immunity is attained through natural infection or vaccinations.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Top news of the week from Pharmacy Times®.

Political insiders Donna L. Brazile and Michael Steele spoke to NASP members about which issues may concern them most and getting involved in the political process.

Although working from home created challenges for contacting stakeholders, some companies saw higher accuracy and fewer sick days among employees.

The keynote presentation will be broadcast virtually on 4 dates this fall and highlight cancer-specific guidance for pharmacists during the COVID-19 pandemic.

A study of Chinese women found COVID-19 heightened stress, fear, and depression during pregnancy.

Following the global impact of COVID-19 on the health care system in 2020, there have been some clear changes in HIV care in the United States.

The growth of telehealth, ongoing prescriber verification challenges, and the need for a universal patient identifier are all key issues that have arisen for pharmacists during the COVID-19 pandemic.

Students at the University of Illinois at Chicago College of Pharmacy answered the question “How has the pandemic impacted your summer internship/residency (or other pharmacy work)?”

In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.

Although the presence of rhinovirus limited the ability of influenza to infect cells, researchers do not know whether the same effect will be seen with COVID-19.

In an interview with Pharmacy Times, National Community Pharmacists Association CEO B. Douglas Hoey, BSPharm, said he’s optimistic about having a vaccine for COVID-19 by the end of the year.

Pharmacy Times® interviewed Steven Lucio, vice president of Pharmacy Solutions at Vizient, on the ways that the COVID-19 pandemic has affected hospital spending this year, which is projected to result in increased drug spending for 2021.

The emergency use of drugs to shorten hospitalization and prolong time for COVID-19 vaccine research and development will serve as a critical temporary buffer for an efficient vaccine to combat SARS-CoV-2.

A new study published in JAMA suggests that prevention of both coronavirus disease 2019 (COVID-19) and seasonal influenza in US children is sensible and important for the well-being of the population.

Researchers at the Rensselaer Polytechnic Institute recently published a study on the use of the FDA-approved anticoagulant heparin in patients with COVID-19.

Top news of the week from Pharmacy Times®.

COVID-19 pandemic highlights how supplements can help improve the body’s defense system.

Contrary to earlier statements from the CDC, study suggests corticosteroid inhalers used by many asthmatics might make it more difficult for COVID-19 to enter the airways.